Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Atorvastatin muscle pain is usually mild, dose-related, and reversible once the drug is lowered or stopped, so permanent damage is uncommon but not impossible. Rarely, statins trigger rhabdomyolysis or statin-associated autoimmune myopathy, which can cause lasting muscle weakness and kidney injury, while liver enzyme elevations are typically temporary and serious liver damage is very rare. Warning signs that need urgent evaluation include severe or widespread muscle pain, dark or cola-colored urine, weakness that worsens after stopping the drug, yellowing of the skin or eyes, and unusual fatigue. Risk rises with higher doses, certain drug interactions, thyroid or kidney problems, and older age, so there are several important factors to consider before assuming your symptoms are harmless. See below to understand more about which symptoms are reversible, which are not, and when testing is needed.
Because muscle aches on a statin can mean anything from a benign side effect to an early sign of a rare but serious reaction, it helps to sort out what your specific pattern of symptoms suggests before your next appointment. A free, instant, online symptom check can help you organize your symptoms, flag red flags that deserve prompt attention, and clarify the questions worth raising with your doctor about continuing, adjusting, or testing while on atorvastatin.
Last reviewed for medical accuracy: 09/12/2026
Can atorvastatin muscle pain lead to permanent muscle or liver damage?
Atorvastatin is one of the most commonly prescribed statin drugs for lowering cholesterol and reducing cardiovascular risk. Like all medications, it can cause side effects—most notably muscle and, less frequently, liver issues. Understanding how often these occur, how serious they can be, and what you can do to monitor and manage them will help you use atorvastatin safely.
Atorvastatin works by blocking an enzyme in the liver that’s involved in cholesterol production. This mechanism can sometimes affect muscle cells and liver enzymes, leading to:
Most people tolerate atorvastatin very well. Clinically significant problems are relatively rare. However, it’s important to recognize warning signs, know when to get checked, and understand how to minimize risk.
Safe use of atorvastatin involves setting up a monitoring plan and knowing when to take action:
If you experience persistent muscle symptoms or significant liver enzyme increases, your doctor may:
You can take steps to minimize the likelihood of atorvastatin side effects:
Most atorvastatin side effects are mild and manageable, but you should contact your healthcare provider or seek urgent care if you experience:
For a free, online symptom check, using the doctor approved Ubie Symptom Checker, click here.
If you ever feel that your symptoms could be life threatening or serious, please speak to a doctor immediately.
(References)
* Ballard KD, Taylor BA, Thompson PD. Statin-associated muscle injury. Eur J Prev Cardiol. 2015 Sep;22(9):1161. doi: 10.1177/2047487315586096. Epub 2015 May 6. PMID: 25948131.
* Ambapkar SN, Shetty N, Dwivedy A. Statin-Induced Rhabdomyolysis. J Assoc Physicians India. 2016 Jul;64(7):93-94. PMID: 27759359.
* Oztas M, Ugurlu S, Aydin O. Atorvastatin-induced dermatomyositis. Rheumatol Int. 2017 Jul;37(7):1217-1219. doi: 10.1007/s00296-017-3658-9. Epub 2017 Feb 25. PMID: 28238074.
* Björnsson ES. Clinical management of patients with drug-induced liver injury (DILI). United European Gastroenterol J. 2021 Sep;9(7):781-786. doi: 10.1002/ueg2.12113. Epub 2021 Jun 28. PMID: 35084797; PMCID: PMC8435256.
* Cholesterol Treatment Trialists' Collaboration. Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials. Lancet. 2022 Sep 10;400(10355):832-845. doi: 10.1016/S0140-6736(22)01545-8. Epub 2022 Aug 29. PMID: 36049498; PMCID: PMC7613583.
* Montastruc JL. Rhabdomyolysis and statins: A pharmacovigilance comparative study between statins. Br J Clin Pharmacol. 2023 Aug;89(8):2636-2638. doi: 10.1111/bcp.15757. Epub 2023 May 8. PMID: 37186323.
* Li XY, Zhong W, Mao YM. [Statin-related drug-induced liver injury]. Zhonghua Gan Zang Bing Za Zhi. 2023 Jun 20;31(6):659-663. doi: 10.3760/cma.j.cn501113-20230418-00174. PMID: 37400395; PMCID: PMC12850668.
* Todorovac N, Krøigård AB, Christiansen AA, Jadou G. Immune-mediated necrotising myopathy after several years of treatment with atorvastatin. Ugeskr Laeger. 2024 Oct 28;186(44). doi: 10.61409/V01240030. PMID: 39534931.
* Zakyrjanova GF, Matigorova VA, Kuznetsova EA, Dmitrieva SA, Tyapkina OV, Tsentsevitsky AN, Andreyanova SN, Odnoshivkina JG, Shigapova RR, Mukhamedshina YO, Gogolev YV, Petrov AM. Key genes and processes affected by atorvastatin treatment in mouse diaphragm muscle. Arch Toxicol. 2025 Jul;99(7):2877-2901. doi: 10.1007/s00204-025-04056-6. Epub 2025 Apr 16. PMID: 40234311.
* Zakyrjanova GF, Tsentsevitsky AN, Matigorova VA, Fedorov NS, Odnoshivkina JG, Sibgatullina GV, Kapliukhina EA, Giniatullin AR, Khaziev AN, Malomouzh AI, Gogolev YV, Petrov AM. Cholesterol-Lowering Treatment Suppresses Neuromuscular Transmission Via Presynaptic Mechanism at the Mouse Diaphragm Muscle. Neurochem Res. 2025 Sep 11;50(5):298. doi: 10.1007/s11064-025-04550-4. Epub 2025 Sep 11. PMID: 40932671.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.